Cargando…
Impfungen gegen COVID-19 – was haben wir gelernt?
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638500/ https://www.ncbi.nlm.nih.gov/pubmed/36373141 http://dx.doi.org/10.1007/s12688-022-00571-x |
| _version_ | 1784825428330938368 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9638500 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Vienna |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96385002022-11-07 Impfungen gegen COVID-19 – was haben wir gelernt? Rheuma Plus Aktuell Springer Vienna 2022-11-04 2022 /pmc/articles/PMC9638500/ /pubmed/36373141 http://dx.doi.org/10.1007/s12688-022-00571-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Aktuell Impfungen gegen COVID-19 – was haben wir gelernt? |
| title | Impfungen gegen COVID-19 – was haben wir gelernt? |
| title_full | Impfungen gegen COVID-19 – was haben wir gelernt? |
| title_fullStr | Impfungen gegen COVID-19 – was haben wir gelernt? |
| title_full_unstemmed | Impfungen gegen COVID-19 – was haben wir gelernt? |
| title_short | Impfungen gegen COVID-19 – was haben wir gelernt? |
| title_sort | impfungen gegen covid-19 – was haben wir gelernt? |
| topic | Aktuell |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638500/ https://www.ncbi.nlm.nih.gov/pubmed/36373141 http://dx.doi.org/10.1007/s12688-022-00571-x |